Biotech · Private company
Engrail Therapeutics INC
Track this companyFree. Adds Engrail Therapeutics INC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ENX-101Phase 2 · Focal EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- ENX-102Phase 2 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ENX-102Phase 2 · Social Anxiety Disorder (SAD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety DisorderPHASE2 · COMPLETED · started Sep 5, 2025ClinicalTrials.gov NCT07193563 · fetched Nov 12, 2026
- ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety DisorderPHASE2 · COMPLETED · started Jul 3, 2023ClinicalTrials.gov NCT05749055 · fetched Nov 12, 2026
- ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal SeizuresPHASE2 · WITHDRAWN · started Sep 1, 2022ClinicalTrials.gov NCT05481905 · fetched Nov 12, 2026